Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Accrued Liabilities Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accrued Liabilities
$47.9m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Accrued Liabilities
CA$42k
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Accrued Liabilities
$26.3m
CAGR 3-Years
59%
CAGR 5-Years
131%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Accrued Liabilities?
Accrued Liabilities
47.9m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Accrued Liabilities amounts to 47.9m USD.

What is Aurinia Pharmaceuticals Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
20%

Over the last year, the Accrued Liabilities growth was 8%. The average annual Accrued Liabilities growth rates for Aurinia Pharmaceuticals Inc have been 20% over the past three years .

Back to Top